Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Book
|
The Unequal Pandemic: COVID-19 and Health InequalitiesBristol University Press ;Bristol University Press 2021 ;ISBN: 9781447361237 ;ISBN: 1447361237 ;ISBN: 1447361253 ;ISBN: 9781447361251 ;EISBN: 1447361253 ;EISBN: 9781447361244 ;EISBN: 1447361245 ;EISBN: 9781447361251 ;DOI: 10.46692/9781447361251 ;OCLC: 1257077799Full text available |
|
2 |
Material Type: Book
|
Coronavirus Politics : The Comparative Politics and Policy of COVID-19https://creativecommons.org/licenses/by-nc/4.0/legalcode ;Ann Arbor, Michigan : University of Michigan Press, ©2021 ;ISBN: 0472902466 ;ISBN: 9780472902460 ;ISBN: 9780472038626 ;ISBN: 0472038621 ;EISBN: 0472902466 ;EISBN: 9780472902460 ;DOI: 10.3998/mpub.11927713 ;LCCallNum: RA644.C67Full text available |
|
3 |
Material Type: Book
|
COVID-19 in the Environment: Impact, Concerns, and Management of CoronavirusISBN: 0323902723 ;ISBN: 9780323902724 ;EISBN: 9780323902731 ;EISBN: 0323902731 ;DOI: 10.1016/C2020-0-03518-8 ;OCLC: 1269096029Full text available |
|
4 |
Material Type: Article
|
BNT162b vaccines protect rhesus macaques from SARS-CoV-2Nature (London), 2021-04, Vol.592 (7853), p.283-289 [Peer Reviewed Journal]Copyright Nature Publishing Group Apr 8, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-03275-y ;PMID: 33524990Full text available |
|
5 |
Material Type: Article
|
Correction: Evolution and consequences of individual responses during the COVID-19 outbreakPloS one, 2023-10, Vol.18 (10), p.e0292775-e0292775 [Peer Reviewed Journal]COPYRIGHT 2023 Public Library of Science ;2023 Abbas et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 Abbas et al 2023 Abbas et al ;2023 Abbas et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0292775Full text available |
|
6 |
Material Type: Article
|
Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 VariantNew England Journal of Medicine, 2021-05, Vol.384 (20), p.1885-1898 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2102214 ;PMID: 33725432Digital Resources/Online E-Resources |
|
7 |
Material Type: Article
|
Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control studyBMJ (Online), 2021-05, Vol.373, p.n1088-n1088 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. BMJ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2021 BMJ ;ISSN: 1756-1833 ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.n1088 ;PMID: 33985964Full text available |
|
8 |
Material Type: Article
|
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7Nature (London), 2021-05, Vol.593 (7857), p.130-135 [Peer Reviewed Journal]Copyright Nature Publishing Group May 6, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-03398-2 ;PMID: 33684923Full text available |
|
9 |
Material Type: Article
|
Correction: Predictors of post-COVID symptoms in Egyptian patients: Drugs used in COVID-19 treatment are incriminatedPloS one, 2022-07, Vol.17 (7), p.e0271154-e0271154 [Peer Reviewed Journal]COPYRIGHT 2022 Public Library of Science ;2022 The PLOS ONE Staff. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 The PLOS ONE Staff 2022 The PLOS ONE Staff ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0271154 ;PMID: 35789344Full text available |
|
10 |
Material Type: Article
|
SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impactNature reviews. Immunology, 2022-01, Vol.22 (1), p.57-65 [Peer Reviewed Journal]2021. Springer Nature Limited. ;COPYRIGHT 2022 Nature Publishing Group ;Springer Nature Limited 2021. ;Springer Nature Limited 2021 ;ISSN: 1474-1733 ;EISSN: 1474-1741 ;DOI: 10.1038/s41577-021-00662-4 ;PMID: 34876702Full text available |
|
11 |
Material Type: Article
|
Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infectionNature medicine, 2021-11, Vol.27 (11), p.2032-2040 [Peer Reviewed Journal]2021. The Author(s). ;COPYRIGHT 2021 Nature Publishing Group ;The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/s41591-021-01540-1 ;PMID: 34588689Full text available |
|
12 |
Material Type: Conference Proceeding
|
Factors Influencing Parental Intent to Vaccinate Children Against COVID-19 in the United StatesAnnals of family medicine, 2023, Vol.21 (Suppl 3) [Peer Reviewed Journal]2023 Annals of Family Medicine, Inc. 2023 ;ISSN: 1544-1709 ;EISSN: 1544-1717 ;DOI: 10.1370/afm.22.s1.4732Full text available |
|
13 |
Material Type: Conference Proceeding
|
COVID-19 case counts, individual immune function and pathogen avoidance motivationAnnals of family medicine, 2023, Vol.21 (Suppl 3) [Peer Reviewed Journal]2023 Annals of Family Medicine, Inc. 2023 ;ISSN: 1544-1709 ;EISSN: 1544-1717 ;DOI: 10.1370/afm.22.s1.4840Full text available |
|
14 |
Material Type: Conference Proceeding
|
Impact of the COVID-19 Pandemic on Attendance at the 18-month-old Developmental Screening VisitAnnals of family medicine, 2023, Vol.21 (Suppl 3) [Peer Reviewed Journal]2023 Annals of Family Medicine, Inc. 2023 ;ISSN: 1544-1709 ;EISSN: 1544-1717 ;DOI: 10.1370/afm.22.s1.5503Full text available |
|
15 |
Material Type: Conference Proceeding
|
Changes in the roles of primary care administrative staff during COVID-19: Results from a cross-provincial qualitative studyAnnals of family medicine, 2023, Vol.21 (Suppl 3) [Peer Reviewed Journal]2023 Annals of Family Medicine, Inc. 2023 ;ISSN: 1544-1709 ;EISSN: 1544-1717 ;DOI: 10.1370/afm.22.s1.5083Full text available |
|
16 |
Material Type: Conference Proceeding
|
Clinical Outcomes of Children Admitted with COVID-19Annals of family medicine, 2023, Vol.21 (Suppl 3) [Peer Reviewed Journal]2023 Annals of Family Medicine, Inc. 2023 ;ISSN: 1544-1709 ;EISSN: 1544-1717 ;DOI: 10.1370/afm.22.s1.4737Full text available |
|
17 |
Material Type: Conference Proceeding
|
Primary prevention and screening during the COVID-19 pandemic: Qualitative findings from the BETTER WISE projectAnnals of family medicine, 2023, Vol.21 (Suppl 3) [Peer Reviewed Journal]2023 Annals of Family Medicine, Inc. 2023 ;ISSN: 1544-1709 ;EISSN: 1544-1717 ;DOI: 10.1370/afm.22.s1.4973Full text available |
|
18 |
Material Type: Conference Proceeding
|
Community Health Centers Rapid Adoption of Telemedicine during the COVID-19 pandemic: a mixed methods studyAnnals of family medicine, 2023, Vol.21 (Suppl 3) [Peer Reviewed Journal]2023 Annals of Family Medicine, Inc. 2023 ;ISSN: 1544-1709 ;EISSN: 1544-1717 ;DOI: 10.1370/afm.22.s1.4956Full text available |
|
19 |
Material Type: Conference Proceeding
|
Diagnostic Phenotypes of Post-Acute Sequelae Following COVID-19 Leveraging the American Family Cohort, PRIME RegistryAnnals of family medicine, 2023, Vol.21 (Suppl 3) [Peer Reviewed Journal]2023 Annals of Family Medicine, Inc. 2023 ;ISSN: 1544-1709 ;EISSN: 1544-1717 ;DOI: 10.1370/afm.22.s1.5288Full text available |
|
20 |
Material Type: Conference Proceeding
|
Missed Healthcare Visits during the COVID-19 Pandemic: A Longitudinal StudyAnnals of family medicine, 2023, Vol.21 (Suppl 3) [Peer Reviewed Journal]2023 Annals of Family Medicine, Inc. 2023 ;ISSN: 1544-1709 ;EISSN: 1544-1717 ;DOI: 10.1370/afm.22.s1.5559Full text available |